super quad phase detection
Scope
Date
~
-
Asset management
South Korean brokerages woo super-rich to make them even richer
South Korea’s baby boomers, the demographic cohort born between 1955 and 1963, have largely built their wealth through hard work, savings and ...
4 HOURS AGO
-
Bio & Pharma
Korean biotech Bertis to join BIO 2024 for global reach
South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...
May 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Lunit buys breast cancer detection AI firm Volpara Health
Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI ...
May 22, 2024 (Gmt+09:00)
-
Short selling
Korea builds system to speed up naked short-selling ban
South Korea’s top financial regulator is set to build a centralized digital system to strengthen the prevention of naked short-selling as the ...
Apr 25, 2024 (Gmt+09:00)
-
Korean startups
Korean unicorns’ failed global expedition causes growth concern
Woowa Brothers Corp. and Viva Republica Inc., South Korea’s most valuable unicorns, have pulled the plug on some of their overseas businesses ...
Apr 16, 2024 (Gmt+09:00)
-
Banking & Finance
Samsung seeks to launch new super mobile banking app with a local bank
Samsung Financial Networks, a union of Samsung Group’s four financial affiliates, is seeking to launch a super mobile banking app in partnersh...
Mar 25, 2024 (Gmt+09:00)
-
Artificial intelligence
Lunit gets court approval for Volpara acquisition in New Zealand
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...
Mar 14, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
Naver, Aramco to team up to enter Saudi Arabia
South Korea’s online giant Naver Corp. announced on Wednesday that it signed an agreement with Aramco Digital, a subsidiary of the world's lar...
Mar 06, 2024 (Gmt+09:00)
-
Robotics
Lotte, Neubility to develop autonomous security robots
South Korea's Lotte Data Communication Co. signed a memorandum of understanding (MOU) with a domestic autonomous robot service company Neubility on ...
Mar 04, 2024 (Gmt+09:00)
-
Bio & Pharma
SK C&C wins Korea’s nod for brain infarct diagnosis AI solution
SK Inc C&C (SK C&C), the information technology service unit of South Korea’s SK Group, said on Thursday it has secured medical device...
Feb 22, 2024 (Gmt+09:00)
-
Electronics
Samsung to unveil Galaxy Fit3 in global market
Samsung Electronics Co. announced on Thursday that it will release its new fitness band, the Galaxy Fit3. The device features an expansive 40mm di...
Feb 22, 2024 (Gmt+09:00)
-
Artificial intelligence
LG to use AI for early detection of air conditioner anomalies
LG Electronics Inc. has introduced an artificial intelligence technology for early detection of anomalies in its commercial air conditioning systems...
Feb 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Construction
POSCO E&C develops solution for detecting wall cracks by drones
South Korea's POSCO E&C has developed a solution for apartment exterior wall maintenance using drones.The company announced on Tuesday that it h...
Jan 23, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Artificial intelligence
DeepBrain AI launches deepfake detection solution
South Korean AI startup DeepBrain AI announced on Friday that it released the country's first service-as-a-software (SaaS)-based deepfake detection ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Short selling
Korea’s top regulator detects more foreigners’ naked shorting
South Korea’s top financial regulator is detecting more circumstances of naked short-selling worth tens of millions of dollars by foreign inve...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Real estate
Myeong-dong cements status as super-prime real estate in Korea
A 170-square-meter plot of land in Myeong-dong, central Seoul, where South Korean beauty brand Nature Republic’s flagship store is located, ha...
Dec 20, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Systems to develop swift, accurate mine detection tech
South Korea's Hanwha Systems Co. is set to embark on the development of a mine detection system using big data and artificial intelligence (AI) tech...
Dec 15, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to develop submarine technology to evade detection
South Korea's Hanwha Ocean Co. has consecutively secured contracts for naval technology-related vessel research projects. The company recently annou...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Artificial intelligence
LG Innotek detects design flaws using AI tech
South Korean electronic parts manufacturer LG Innotek announced on Tuesday it has implemented an artificial intelligence (AI) analysis system to qui...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)